This Cochrane Clinical Answer evaluates angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression of diabetic kidney disease.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.